Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemopathies”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Not applicableStudy completedNCT02140736
What this trial is testing

Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology

Who this might be right for
Chemotherapy-induced Symptomatic AnemiaSolid TumorsMalignant Hemopathies+2 more
Hospira, now a wholly owned subsidiary of Pfizer 2,333
Not applicableNot Yet RecruitingNCT04702932
What this trial is testing

Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaWaldenstrom Macroglobulinemia
Assistance Publique - Hôpitaux de Paris 30
Early research (Phase 1)Active Not RecruitingNCT03232268
What this trial is testing

HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid Hemopathies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Institut Paoli-Calmettes 25
Not applicableLooking for participantsNCT06713811
What this trial is testing

Evaluation of the Impact of Electronic Monitoring on Patient Compliance in Hematology

Who this might be right for
Hemopathies
Private Hospital of Confluent, France 110
Not applicableUnknownNCT04057443
What this trial is testing

Nutritional and Physical Exercise Intervention in Older Patients With Malignant Hemopathies

Who this might be right for
Hematologic MalignancyOld Age; Debility
Maite Antonio, MD, Phd 80
Not applicableEnded earlyNCT01546337
What this trial is testing

Search for Predictive Markers of Efficacy of ESAs in Patients With Non-myeloid Malignancies or Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromesAnemiaHemopathies
Rennes University Hospital 30
Not applicableStudy completedNCT03883672
What this trial is testing

Socio-psychological Factors Involved in the Hematopoietic Stem Cell Transplantation Process in People With Hemopathies

Who this might be right for
Leukemia
Saint-Louis Hospital, Paris, France 280
Not applicableLooking for participantsNCT04090268
What this trial is testing

Precision Exercise in Children With Malignant Hemopathies

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, B-cellLeukemia, T Cell+5 more
University of Milano Bicocca 380
Large-scale testing (Phase 3)Study completedNCT01110824
What this trial is testing

Prevention of Left Ventricular Dysfunction During Chemotherapy

Who this might be right for
Acute Myeloid LeukemiaPrecursor-cell Lymphoblastic Leukemia-LymphomaLymphoid Neoplasm+3 more
Hospital Clinic of Barcelona 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04451200
What this trial is testing

Sequential and Personalized PK-guided Busulfan Administration in the Frame of the Conditiong Regimen for Allo-HSCT in Patients With Malignant Hemopathies Ineligible for the Standard Myeloablative Conditioning

Who this might be right for
Acute LeukemiaMielodysplasic SyndromeMyeloproliferative Neoplasm
Institut Paoli-Calmettes 82
Not applicableLooking for participantsNCT06022016
What this trial is testing

Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene.

Who this might be right for
DDX41 Gene Mutation
Institut Claudius Regaud 910
Not applicableStudy completedNCT01069887
What this trial is testing

A Prospective Registry for Febrile Events in Patients With Malignant Hemopathies or Subjected to Haematopoietic Stem Cell Transplant

Who this might be right for
Hematological MalignanciesStem Cell Transplantation
Catholic University of the Sacred Heart 3,000